Literature DB >> 21242400

Is topical monotherapy effective for localized pyoderma gangrenosum?

Laurence Le Cleach1, Philippe Moguelet, Pascal Perrin, Olivier Chosidow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21242400     DOI： 10.1001/archdermatol.2010.393

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  7 in total

1.  [Progressive ulceration of the periorbital region].

Authors:  A Frings; V Frings; G Geerling; M Goebeler; M Schargus
Journal:  Ophthalmologe       Date:  2018-02       Impact factor: 1.059

Review 2.  Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors:  Jurij Hanzel; Christopher Ma; Niels Vande Casteele; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

3.  Update in the management of extraintestinal manifestations of inflammatory bowel disease.

Authors:  Seema A Patil; Raymond K Cross
Journal:  Curr Gastroenterol Rep       Date:  2013-03

4.  Facial pyoderma gangrenosum in senescence.

Authors:  Dorothea Kratzsch; Mirjana Ziemer; Linda Milkova; Justinus A Wagner; Jan C Simon; Michael Kendler
Journal:  Case Rep Dermatol       Date:  2013-10-11

5.  Negative Pressure Wound Therapy in Pyoderma Gangrenosum Treatment.

Authors:  Dariusz Bazaliński; Anna Karwiec; Marek Kucharzewski; Paweł Więch
Journal:  Am J Case Rep       Date:  2020-06-10

6.  Pyoderma gangrenosum in an abdominal surgical site: a case report.

Authors:  Kenichi Ogata; Hiroshi Takamori; Yoshiaki Ikuta; Hideyuki Tanaka; Nobuyuki Ozaki; Hiromitsu Hayashi; Katsuhiro Ogawa; Koichi Doi
Journal:  Surg Case Rep       Date:  2015-12-09

Review 7.  Recent advances in managing and understanding pyoderma gangrenosum.

Authors:  Josh Fletcher; Raed Alhusayen; Afsaneh Alavi
Journal:  F1000Res       Date:  2019-12-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.